¿Cómo Podemos Ayudarle?

Puede haber opciones para ayudarle a cubrir los gastos de VENCLEXTA, independientemente del tipo de seguro médico que posea.

Derivación a Fundaciones Independientes de Asistencia al Copago

Si necesita ayuda con el copago de VENCLEXTA, VENCLEXTA Access Solutions puede derivarle a una fundación independiente de asistencia al copago.

Una fundación independiente de asistencia al copago es una organización benéfica que proporciona asistencia financiera para medicamentos.

Llame a VENCLEXTA Access Solutions en el (888) 249-4918 para que le deriven.

Si desea ponerse en contacto directamente con una fundación, puede usar la información que se indica a continuación:

Patient Access Network Foundation (PANF)
P.O. Box 221858
Charlotte, NC 28222-1858
Toll Free: 1-866-316-PANF (7263)
www.panfoundation.org

The Leukemia and Lymphoma Society
1311 Mamaroneck Avenue, Suite 310
White Plains, NY 10605
Toll Free: 1-877-557-2672 (877-LLS-COPAY)
www.lls.org/copay

La fundaciones independientes de asistencia al copago tienen sus propias normas para elegibilidad. No podemos garantizarle que una fundación le vaya a ayudar. Solo podemos derivarle para que esta le asista con su estado de salud. Esta información solo se la proporcionamos a modo informativo. No respaldamos ni mostramos preferencia económica por ninguna fundación en particular. Las fundaciones de esta lista no son las únicas que pueden ayudarle.

Derivaciones a la fundación Genentech Patient Foundation

La fundación Genentech® Access to Care Foundation ahora es Genentech Patient Foundation.

Aún nos enfocamos en proporcionar medicamentos gratuitos a los pacientes necesitados, pero hemos realizado algunos cambios para ofrecer mejor asistencia a más pacientes, más rápido.

Genentech Patient Foundation proporciona medicamentos gratuitos a las personas:

  • Que no tienen seguro
  • Cuyo tratamiento no está cubierto por el seguro
  • Que tienen dificultades con sus elevados costos que deben abonar de su bolsillo 

Para obtener más información y solicitar ayuda, visite GenentechPatientFoundation.com.

Si cuenta con cobertura de un seguro médico para su medicamento, primero debe haber probado otros tipos de asistencia a pacientes para ser apto para recibir VENCLEXTA gratis a través de la Genentech Patient Foundation. Esto incluye la ayuda de fundaciones independientes de asistencia al copago. También debe cumplir otros criterios financieros. Si no tiene seguro o si su seguro no cubre su medicamento, debe cumplir unos criterios financieros diferentes.

Cómo Trabajar con VENCLEXTA Access Solutions

Paso 1

Suscríbase a VENCLEXTA Access Solutions.

¿Cómo me inscribo?

Paso 2

Trabajamos con usted, con la consulta de su médico, su plan de seguro médico y su farmacia especializada. Podríamos ponernos en contacto con usted para recabar más información.

¿Qué averiguaremos?

Paso 3

Le derivamos a las opciones de asistencia a pacientes.

¿Qué opciones hay?

PAN=siglas en inglés de Autorización del Paciente y Aviso de Solicitud Para Transmitir Información Médica a Genentech Access Solutions y a Genentech® Access to Care Foundation.

SMN=siglas en inglés de Declaración de Necesidad Médica.

Important Safety Information & Indication

Use and Important Safety Information

Use

What is VENCLEXTA® (venetoclax tablets)?

VENCLEXTA is a prescription medicine used to treat people with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL), with or without 17p deletion, who have received at least one prior treatment.

It is not known if VENCLEXTA is safe and effective in children.

Important Safety Information

What is the most important information I should know about VENCLEXTA?

VENCLEXTA can cause serious side effects, including:

Tumor lysis syndrome (TLS). TLS is caused by the fast breakdown of cancer cells. TLS can cause kidney failure, the need for dialysis treatment, and may lead to death. Your healthcare provider will do tests for TLS. It is important to keep your appointments for blood tests. You will receive other medicines before starting and during treatment with VENCLEXTA to help reduce your risk of TLS. You may also need to receive intravenous (IV) fluids into your vein. Tell your healthcare provider right away if you have any symptoms of TLS during treatment with VENCLEXTA, including fever, chills, nausea, vomiting, confusion, shortness of breath, seizures, irregular heartbeat, dark or cloudy urine, unusual tiredness, or muscle or joint pain.

Drink plenty of water when taking VENCLEXTA to help reduce your risk of getting TLS.
Drink 6 to 8 glasses (about 56 ounces total) of water each day, starting 2 days before your first dose,
on the day of your first dose of VENCLEXTA, and each time your dose is increased.

Who should not take VENCLEXTA? 

Certain medicines must not be taken when you first start taking VENCLEXTA and while your dose is being slowly increased because of the risk of increased tumor lysis syndrome.

  • Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. VENCLEXTA and other medicines may affect each other, causing serious side effects.
  • Do not start new medicines during treatment with VENCLEXTA without first talking with your healthcare provider.

Before taking VENCLEXTA, tell your healthcare provider about all of your medical conditions, including if you:

  • Have kidney or liver problems.
  • Have problems with your body salts or electrolytes, such as potassium, phosphorus, or calcium.
  • Have a history of high uric acid levels in your blood or gout.
  • Are scheduled to receive a vaccine. You should not receive a “live vaccine” before, during, or after treatment with VENCLEXTA until your healthcare provider tells you it is okay. If you are not sure about the type of immunization or vaccine, ask your healthcare provider. These vaccines may not be safe or may not work as well during treatment with VENCLEXTA.
  • Are pregnant or plan to become pregnant. VENCLEXTA may harm your unborn baby. If you are able to become pregnant, your healthcare provider should do a pregnancy test before you start treatment with VENCLEXTA, and you should use effective birth control during treatment and for 30 days after the last dose of VENCLEXTA.
  • Are breastfeeding or plan to breastfeed. It is not known if VENCLEXTA passes into your breast milk. Do not breastfeed during treatment with VENCLEXTA.

What should I avoid while taking VENCLEXTA?

You should not drink grapefruit juice or eat grapefruit, Seville oranges (often used in marmalades),
or starfruit while you are taking VENCLEXTA. These products may increase the amount of VENCLEXTA in your blood.

What are the possible side effects of VENCLEXTA?

VENCLEXTA can cause serious side effects, including:

  • Low white blood cell count (neutropenia). Low white blood cell counts are common with VENCLEXTA but can also be severe. Your healthcare provider will do blood tests to check your blood counts during treatment with VENCLEXTA. Tell your healthcare provider right away if you have a fever or any signs of an infection.

The most common side effects of VENCLEXTA when used in combination with rituximab include low white blood cell count, diarrhea, upper respiratory tract infection, cough, tiredness, and nausea.

The most common side effects of VENCLEXTA when used alone include low white blood cell count, diarrhea, nausea, upper respiratory tract infection, low red blood cell count, tiredness, low platelet count, muscle and joint pain, swelling of your arms, legs, hands, and feet, and cough.

VENCLEXTA may cause fertility problems in males. This may affect your ability to father a child. Talk to your healthcare provider if you have concerns about fertility.

These are not all the possible side effects of VENCLEXTA. Tell your healthcare provider if you have any side effect that bothers you or that does not go away.

For additional safety information, please see the full Prescribing Information and Medication Guide.